Open access · Peer reviewed · Scopus journal
Angioedema due to fixed dose combination of telmisartan plus ramipril
- 1*,
- 2,
- 1,
- 1
- 1Department of Pharmacology and Therapeutic, College, Jammu, Jammu and Kashmir, India Case Report.
- 2Department of General Medicine, Government Medical College, Jammu, Jammu and Kashmir, India Case Report.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Vishal R. Tandon
Department of Pharmacology and Therapeutic, College, Jammu, Jammu and Kashmir, India Case Report.
Copyright: © 2014 The Author(s). This is an open access article.
Published: Jan 1, 2014, Received: Aug 3, 2013, Accepted: Jan 16, 2014
Abstract
The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin‑converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension.
Keywords
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026